Manic psychosis induced by long term alpha-interferon treatment for hepatitis C

被引:0
|
作者
Howes, OD
McKenzie, KJ
机构
[1] Maudsley Hosp, London SE5 8AF, England
[2] Inst Psychiat, London, England
关键词
mania; psychosis; alpha-interferon; olanzapine; sodium valproate;
D O I
10.3109/13651500009178004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
There is increasing evidence of psychiatric sine-effects following long-term alpha-interferon treatment, but no previous reports of psychosis as a side-effect. There is little evidence to suggest the best treatment of interferon-related psychiatric illness. A case of manic pyschosis developing after long-term alpha-interferon treatment is reported in a woman with no previous psychiatric history. The patient did not respond to termination of alpha-interferon therapy. She responded partially to olanzapine but completely recovered after sodium valproate was added, with no deleterious effects. Psychiatric sine-effects, including psychosis, are appreciable problems of alpha-interferon. This is the first case report of psychosis developing after long-term treatment. It supports suggestions that the pathological mechanisms of the early and late side-effects are different. Sodium valproate proved to be a safe and effective treatment.
引用
收藏
页码:161 / 162
页数:2
相关论文
共 50 条
  • [1] A case of interferon alpha-induced manic psychosis in chronic hepatitis C
    Kanno, A
    Yamada, M
    Abe, M
    Okamoto, Y
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 187 (01) : 79 - 82
  • [2] Acute hepatitis induced by alpha-interferon in a patient with chronic hepatitis C
    Kraus, I
    Vitezic, D
    CANADIAN JOURNAL OF GASTROENTEROLOGY, 2001, 15 (05): : 333 - 335
  • [3] Long-term efficacy of treatment of chronic hepatitis C with alpha interferon or alpha interferon and ribavirin
    Barnes, E
    Webster, G
    Jacobs, R
    Dusheiko, G
    JOURNAL OF HEPATOLOGY, 1999, 31 : 244 - 249
  • [4] Parameters predicting response to alpha-interferon treatment in chronic hepatitis C
    Gluck, T
    Seelig, R
    Dette, S
    Buhring, HJ
    Renz, M
    Kwon, S
    Wiedmann, KH
    Weber, P
    HEPATO-GASTROENTEROLOGY, 1997, 44 (14) : 484 - 491
  • [5] LONG-TERM HISTOLOGIC AND VIRAL CHANGES IN PATIENTS WITH CHRONIC HEPATITIS-C WHO RESPONDED TO ALPHA-INTERFERON
    MARCELLIN, P
    BOYER, N
    DEGOTT, C
    MARTINOTPEIGNOUX, M
    DUCHATELLE, V
    GIOSTRA, E
    AREIAS, J
    ERLINGER, S
    BENHAMOU, JP
    LIVER, 1994, 14 (06): : 302 - 307
  • [6] Antioxidant drugs combined with alpha-interferon in chronic hepatitis C not responsive to alpha-interferon alone:: a randomized, multicentre study
    Idéo, G
    Bellobuono, A
    Tempini, S
    Mondazzi, L
    Airoldi, A
    Benetti, G
    Bissoli, F
    Cestari, C
    Colombo, E
    Del Poggio, P
    Fracassetti, O
    Lazzaroni, S
    Marelli, A
    Paris, B
    Prada, A
    Rainer, E
    Roffi, L
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 1999, 11 (11) : 1203 - 1207
  • [7] Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C
    Markowitz, JS
    Gutterman, EM
    Hodes, D
    Klaskala, W
    JOURNAL OF VIRAL HEPATITIS, 2005, 12 (02) : 176 - 185
  • [8] HEPATITIS-DELTA SUPERINFECTION DURING ALPHA-INTERFERON TREATMENT FOR HEPATITIS-B
    CRAXI, A
    DIMARCO, V
    BRUNO, R
    FABIANO, C
    ITALIAN JOURNAL OF GASTROENTEROLOGY, 1992, 24 (01): : 19 - 21
  • [9] Long-lasting complete remission of hepatitis C virus (HCV) infection and HCV-associated immunocytoma with alpha-interferon treatment
    Patriarca, F
    Silvestri, F
    Fanin, R
    Zaja, F
    Sperotto, A
    Baccarani, M
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 112 (02) : 370 - 372
  • [10] Development of arthritis and hypothyroidism during alpha-interferon therapy for chronic hepatitis C
    Pittau, E
    Bogliolo, A
    Tinti, A
    Mela, Q
    Ibba, G
    Salis, G
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1997, 15 (04) : 415 - 419